Home monitoring program for high-risk AMD candidates may have public health impact

VIENNA — Broader implementation of a home monitoring program for detecting early AMD in patients at high risk for developing the disease may potentially impact public health in the U.S., according to an analysis presented here. OSN Retina/Vitreous Board Member Carl D. Regillo, MD, discussed the potential public health impact of the Foresee Home AMD monitoring program, which uses preferential hyperacuity perimetry to help diagnose choroidal neovascularization (CNV) in its earliest stages.